Clinical Trials on Hematological Abnormality

Total 15764 results

Novartis Pharmaceuticals

Completed

A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

Hematological Malignancies

Germany, Switzerland, France
Beijing Immunochina Medical Science & Technology...

Unknown

Safety and Efficacy Evaluation of IM19 Cells

Hematological Malignancies

China
Agennix

Withdrawn

Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies

Hematological Malignancies
Azienda Ospedaliera San Giovanni Battista

Completed

Nonmyeloablative Stem Cell Transplant in Elderly

Hematological Malignancies

Italy
University Of Perugia

Unknown

Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies

Hematological Malignancies

Italy
General Hospital Groeninge

Completed

Central Venous Access Device Removal in Cancer Patients

Oncology | Haematological Malignancy

Belgium
Abramson Cancer Center at Penn Medicine

Not yet recruiting

FAPI-74 PET/CT in Adults With Fibrosis

Fibrosis (Morphologic Abnormality)

United States
Agricultural University of Athens
Institute of Technology and Agricultural Products

Completed

Determining the Glycemic Effects of Sunflower Pasta

Appetitive Behavior | Potential Abnormality of Glucose Tolerance

Greece
Agricultural University of Athens

Completed

Characterizing Emmer Seeds and Flours, and Determining the Glycemic Effects of Emmer Breads

Appetitive Behavior | Potential Abnormality of Glucose Tolerance

Greece
Agricultural University of Athens

Completed

Effects of Sugar-free Products With Added Sweeteners on Glycemic Responses

Appetitive Behavior | Potential Abnormality of Glucose Tolerance

Greece
Agricultural University of Athens

Completed

Effects of Traditional Greek Meals on Glycemic Responses

Appetitive Behavior | Potential Abnormality of Glucose Tolerance

Greece
Hutchmed

Not yet recruiting

A Clinical Study of HMPL-506 in Patients With Hematological Malignancies

Hematological Malignancies
Miltenyi Biomedicine GmbH
City of Hope Comprehensive Cancer Center

Not yet recruiting

M-2018-334 in Hematological Malignancies (HAPLO2022)

Hematological Malignancies
Smart Immune SAS

Recruiting

Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide

Hematological Malignancies

France
Smart Immune SAS

Recruiting

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT

Hematological Malignancies

United States
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions

Hematological Malignancies

China
Gilead Sciences

Terminated

Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies

Hematological Malignancies

United States, United Kingdom
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)

Hematological Malignancies

United States, Canada, Brazil, Chile, Denmark, France, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)

Hematological Malignancies

China
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Dutch...

Completed

MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT (PSCT19)

Hematological Malignancies

Netherlands
Wei Zhao
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Unknown

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Hematological Neoplasms

China
M.D. Anderson Cancer Center

Completed

Study of ABT-751 in Patients With Refractory Hematologic Malignancies

Hematological Malignancies

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

Hematological Malignancies

United States
University of Pavia
Fondazione Salvatore Maugeri; IRCCS Policlinico S. Matteo

Unknown

Molecular Disease Profile of Hematological Malignancies (RELab1)

Hematological Malignancies

Italy
Hospices Civils de Lyon

Unknown

Extracorporal Photopheresis Pilot Study (ECP)

Hematological Malignancies

France
Qilu Hospital of Shandong University

Not yet recruiting

Diagnosis of Structural Heart Disease Using MCG

Structural Heart Abnormality
GE Healthcare
Laboratory Corporation of America

Completed

Study to Determine Safety and Dosage of OPTISON in Pediatric Participants

Transthoracic Echocardiography | Suspected or Known Structural or Functional Cardiac Abnormality

United States
University Hospital, Lille
Ministry of Health, France

Completed

Antenatal Detection by Array CGH Genomic Rearrangements Unbalanced Front Uninsulated Thick Neck or a Combination of Two Signs of Ultrasound Calling Normal Karyotype (CGH Array)

Abnormality of the Neck | Fetus; Abnormal, Affecting Management of Pregnancy

France
Institut Paoli-Calmettes
Agence de La Biomédecine

Completed

Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood Diseases (BX-PK)

Hematological Diseases

France
University Hospital, Montpellier
Soroptimist association of Monaco

Recruiting

Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia (ALADIN)

Solid Tumor, Childhood | Pediatric Tumor | Familial Cancer | Hematological Tumor

France
Esanex Inc.

Completed

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

Cancer

United States
Nottingham University Hospitals NHS Trust
Newcastle University; University of Kansas; Macmillan Cancer Support; Bishop Grosseteste...

Terminated

Nutrition Health Literacy of Cancer Patients and Their Support Networks. (NiiCproject)

Cancer | Oncologic Disorders | Nutrition Aspect of Cancer | Haematological Malignancy

United Kingdom
University Hospital Tuebingen
Ludwig-Maximilians - University of Munich; University Hospital Augsburg

Completed

Secondary Haplo HSCT for Relapse After Initial Allogeneic HSCT

Relapse of Hematological Malignancies
Rigshospitalet, Denmark
Danish Cancer Society

Not yet recruiting

AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation (AlloCare)

Hematological Diseases

Denmark
National Cheng-Kung University Hospital

Completed

Application of MT in Subjects With Overweight/Metabolic Abnormality---RCT

Overweight | Metabolic Abnormality

Taiwan
Centre Francois Baclesse

Completed

Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy (TelOG)

Cancer | Hematologic Malignancy

France
Albert Einstein College of Medicine

Recruiting

Hematology Biobank : Invitro Study of Blood Disorders

Hematological Disorders

United States
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological Malignancies

AML

China
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

Clinical Study of CD38 CAR-T Cells in the Treatment of Hematological Malignancies

AML

China
First Affiliated Hospital of Zhejiang University

Recruiting

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Leukemia

China
Armando Santoro, MD

Completed

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Tumors | Hematological Neoplasms

Italy
Investigación en Hemofilia y Fisioterapia

Completed

Load Control in Eccentric Exercises in Volleyball Players

Patellar Abnormality

Spain
University of Campania "Luigi Vanvitelli"

Completed

Ultrasonographic Parameters for Fetal Weight Prediction

Fetal Growth Abnormality

Italy
Institut Paoli-Calmettes

Completed

A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation (ITAC02-01)

Solid Tumor | Hematological Malignancy | Allograft | Allogeneic Cell Transplantaion

France
Seno Medical Instruments Inc.
American College of Radiology

Completed

CONFIDENCE Registry (CONFIDENCE)

Breast Abnormality Diagnosis

Netherlands
Agricultural University of Athens

Completed

Acute Effects of Spirulina on Postprandial Glycemic Responses and Arterial Blood Pressure

Blood Pressure | Appetitive Behavior | Potential Abnormality of Glucose Tolerance

Greece
Ospedale San Carlo Borromeo
Associazione Oncologica Milanese AmoLaVita ONLUS

Not yet recruiting

Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological Malignancies

Cognitive Impairment | Chemo-brain | Haematological Malignancy

Italy
University Hospital, Brest

Recruiting

Optical Genome Mapping in Hematological Malignancies (CARTOGEN)

MDS | ALL | Other Hematologic Malignant Neoplasms

France
Assiut University

Not yet recruiting

Characteristics and Outcomes of Patients With Hematological Malignancies

Haematologic Neoplasm
Children's Hospital of Fudan University

Recruiting

Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology (NiCE)

Solid Tumor | Hematological Malignancies

China

Clinical Trials on Hematological Abnormality

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations